Top Employer-Paid Stories
Teva to buy Allergan’s generic-drug unit for $40.5 billion
By Chitra Somayaji, David WainerA deal by Teva Pharmaceuticals to buy Allergan will make the company the largest maker of generic drugs.
The latest regulatory issues, trends and best practices in providing employer-paid benefits such as health insurance, 401(k) and retirement planning.
A deal by Teva Pharmaceuticals to buy Allergan will make the company the largest maker of generic drugs.